1097 New immunomodulatory roles of NONO pathway during glioma virotherapy

1097 New immunomodulatory roles of NONO pathway during glioma virotherapy

Bibliographic Details
Main Authors:	Hong Jiang, Frederick Lang, Juan Fueyo, Dong Ho Shin, Marta Alonso, Virginia Laspidea, Xuejun Fan, Andrew G Gillard, Jiasen He, Andres Lopez-Rivas, Akhila Parthasarathy, Candelaria Gomez Manzano
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Targeting Innate Immunity in Glioma Therapy
by: Andrew G. Gillard, et al.
Published: (2024-01-01)

Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option
by: Jiasen He, et al.
Published: (2023-01-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
by: Virginia Laspidea, et al.
Published: (2022-04-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Current Approaches for Glioma Gene Therapy and Virotherapy
by: Kaushik Banerjee, et al.
Published: (2021-03-01)

745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models
by: Sara Labiano, et al.
Published: (2021-11-01)

The Exchange of Prisoners between Muslims and the Crusaders (1097-1191)
by: Mona Hamad
Published: (2014-06-01)

Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma
by: Joselle Cook, MD, et al.
Published: (2021-01-01)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
by: Gregory K Friedman, et al.
Published: (2013-02-01)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
by: Junfeng Liu, et al.
Published: (2023-05-01)

P1097: MEK-INHIBITORS IN TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS
by: E. Burtsev, et al.
Published: (2022-06-01)

Spatiotemporal dynamics and optimal control of glioma virotherapy enhanced by MEK Inhibitors
by: M. Kabong Nono, et al.
Published: (2022-06-01)

Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
by: Brenda eAuffinger, et al.
Published: (2013-02-01)

War and memory: Nono, Penderecki, Britten
by: Manuel Pacheco Sánchez
Published: (2017-05-01)

Remission of liquid tumors and SARS-CoV-2 infection: A literature review
by: Dong Ho Shin, et al.
Published: (2022-09-01)

IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
by: Xueqin Chen, et al.
Published: (2023-10-01)

Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
by: Marc Garcia‐Moure, et al.
Published: (2024-04-01)

Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01)

Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model
by: Konrad Gabrusiewicz, et al.
Published: (2015-04-01)

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
by: Ning Liu, et al.
Published: (2020-10-01)

نيقيه عاصمة سلاجقة الروم الاولى (471 - 490هـ/1078م-1097م)
by: Prof. Dr. Abbas Abdul Sattar Abdul Qadir
Published: (2022-12-01)

معادن بلاد الشام خلال الحروب الصليبية 490- 690 هـ/ 1097 – 1290م
by: سعد رمضان محمد الجبوري
Published: (2013-12-01)

Relations between the Fatimids and the Crusaders in the Levant and Egypt (491-567 AH / 1097-1171 AD)
by: M.D.Azhar Ibrahim Shafiq
Published: (2018-11-01)

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.
by: Hong Jiang, et al.
Published: (2014-01-01)

Don Perlimplín en Venecia: Nono y Maderna
by: Soria Olmedo, Andrés
Published: (2017-06-01)

Rethinking the Ornament with/in Luigi Nono’s Late Electroacoustic Works
by: Kevin Gohon
Published: (2019-09-01)

Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
by: Sauson Soldozy, et al.
Published: (2023-06-01)

Cholera Vibrios of nonO1/nonO139 Serogroups in Etiology of Acute Intestinal Infections: Current Situation in Russia and Around the World
by: E. V. Monakhova, et al.
Published: (2016-06-01)

Antibiotic sensitivity of Vibrio cholerae nonO1/nonO139 strains isolated from hydroecosystems in 2016-2017 in Rostov-on-Don
by: E. A. Bereznyak, et al.
Published: (2019-08-01)

Sustained Angiopoietin-2 Expression Disrupts Vessel Formation and Inhibits Glioma Growth
by: Ok-Hee Lee, et al.
Published: (2006-05-01)

Editorial: Oncolytic virotherapy
by: Ahmed Majeed Al-Shammari, et al.
Published: (2023-11-01)

Advances in oncolytic virotherapy
by: Stephen J. Russell, et al.
Published: (2022-04-01)

Molecular genetic characteristics of Vibrio cholerae nonO1/nonO139 strains isolated on the territory of Russian Federation from patients with otitis
by: Elena V. Monakhova, et al.
Published: (2022-09-01)

Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma
by: Marilin S. Koch, et al.
Published: (2022-09-01)

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
by: Mahua Dey, et al.
Published: (2016-09-01)

Martin Iddon, Music at Darmstadt. Nono, Stockhausen, Cage, and Boulez
by: Annelies Fryberger
Published: (2014-07-01)

Edmond Jabès y Luigi Nono: Découvrir la subversion
by: Francisco Deco
Published: (2014-04-01)

DNA-damaging cancer cells to improve virotherapy
by: Marc Garcia-Moure, et al.
Published: (2022-12-01)

Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
by: Marika Lanza, et al.
Published: (2021-04-01)

Persistent diarrhoea in a 5-month-old baby carrying Vibrio cholerae nonO1/nonO139 producing Haitian cholera toxin
by: P. Kumar, et al.
Published: (2018-01-01)